InvestorsHub Logo
Followers 3
Posts 190
Boards Moderated 0
Alias Born 05/16/2013

Re: None

Friday, 09/22/2017 4:39:42 PM

Friday, September 22, 2017 4:39:42 PM

Post# of 426315
ITC Complaint - IT HAD TO HAPPEN SOMETIME. Using just Basic Business Logic (BBL):

Scenario 1) R-IT is successful. This means a) more companies piggybacking on your research (both drug companies and dietary supplement companies) and b) more pressure on supply chain (availability and cost levels).

Solution? You file patent infringement handcuffs on drug companies, and (if FDA can't step up their game on dietary supplement industry), you complain to the ITC for trade violations.

OR

Scenario 2)
R-IT is not successful. That means you have a smaller market, but you still have an approved drug to sell.

Solution? You do exactly the same thing in both scenarios.

There's really no difference in WHY to file an injunction. The only question is WHEN do you do it?

Well, it doesn't make any sense to wait any longer, now that AMRN can absorb the expense of litigation.

There, using BBL I have avoided any need to do any homework related to legal points, such as definitions, labeling, jurisdiction, etc. Nor do I need to trouble myself with the range of possible outcomes.

It simply HAD TO HAPPEN.

When you have your shareholders best interests at heart, you do what you have to do. And AMRN has some very noteworthy shareholders.

Resting somewhat easier here.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News